miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9
Andrea Feliciano(Vall d'Hebron Institut de Recerca), Matilde E. Lleonart(Universitat Autònoma de Barcelona)
Cited by 149
Related Papers
Glycolytic Enzymes Can Modulate Cellular Life Span
|Cancer Research|2005|640
The cancer stem-cell signaling network and resistance to therapy
|Cancer Treatment Reviews|2016|155
miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer
|Cell Death and Disease|2017|103